Myriad Genetics, Inc. (MYGN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 27.90 |
| Open | 27.94 |
| Bid | 28.54 x 200 |
| Ask | 28.65 x 100 |
| Day's Range | 27.91 - 28.82 |
| 52 Week Range | 13.82 - 29.08 |
| Volume | |
| Avg. Volume | 777,180 |
| Market Cap | 2.597B |
| Beta (5Y Monthly) | 1.92 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.77 |
| Earnings Date | Nov 04, 2024 - Nov 08, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 29.77 |
ZacksShould You Continue to Retain MYGN Stock in Your Portfolio?
Myriad Genetics is advancing with strategic priorities, and bringing new products and upgrades to the market, positively influencing investors' sentiment.
GuruFocus.comInsider Sale: Chief Scientific Officer Dale Muzzey Sells Shares of Myriad Genetics Inc (MYGN)
The transaction was documented in a recent SEC Filing. Following this sale, the insider now owns 108,013 shares of Myriad Genetics Inc. Myriad Genetics Inc (NASDAQ:MYGN) is a company that focuses on molecular diagnostic testing.
- GuruFocus.com
Insider Sale: President and CEO Paul Diaz Sells 15,000 Shares of Myriad Genetics Inc (MYGN)
The transaction was documented in a recent SEC Filing. Following this sale, the insider now owns 977,378 shares of Myriad Genetics Inc. Myriad Genetics Inc (NASDAQ:MYGN) is a company that focuses on the discovery and commercialization of novel molecular diagnostic tests.
© 2024 Yahoo. All rights reserved.